About Tridente Labs DTS
Built to connect opportunity with execution.
A 100% Mexican pharmaceutical platform, founder-led, and designed for the regulatory, commercial, and institutional realities of the Mexican market.
A platform, not a project.
Tridente Labs DTS was built as a multidisciplinary pharmaceutical platform — a firm that can plan a regulatory route, navigate public institutions, structure a commercial channel, and frame an industrial opportunity with equal seriousness.
Mexico's health system depends heavily on imported medicines and active ingredients. That dependency is a risk for institutions and an opportunity for serious operators. We work at that intersection: helping manufacturers, investors, and partners turn interest in Mexico into compliant, executable pathways — and supporting the country's longer-term case for local pharmaceutical capability.
Alfonso Dagnino Romo
Founder & Director General
A profile centered on pharmaceutical business development, regulatory execution, distribution strategy, public-sector engagement, and international collaboration — connecting private opportunity with real execution pathways in Mexico.
Founder-led execution
Direct experience across the pathways that matter.
Government medicine supply, regulatory affairs, imports, tenders, and international partnerships — hands-on across the functions a project needs to advance in Mexico.
Public-sector supply
Experience supplying medicines to Mexican federal health institutions.
Regulatory execution
COFEPRIS pathways, GMP alignment, and compliance strategy.
International collaboration
Partner engagement with manufacturers and technology holders abroad.
Business development
Structuring opportunities for investors and industrial partners.
How we operate
Principles that hold up under scrutiny.
Compliance first
We design routes that withstand regulatory and institutional review. Shortcuts that create exposure are not shortcuts.
Institutional seriousness
We prepare for high-level conversations the way they deserve — with clarity, documentation, and respect for process.
Execution over noise
Strategy is judged by whether it moves. We measure ourselves on registrations, supply, and partnerships that close.
Recognition
A national identity, an institutional profile.
Our Hecho en México authorization aligns us with domestic industry, and our positioning is built for public policy, investment, and healthcare-infrastructure conversations.
100% Mexican company
Structured to operate within national industrial strategy and Hecho en México positioning.
Regulatory & commercial execution
COFEPRIS pathways, imports, tenders, and distribution across health categories.
International collaboration
Engagement with GMP-certified manufacturers and technology holders across regions.
Local capability agenda
Advancing the case for domestic pharmaceutical manufacturing, including insulin localization.
Contact
Work with a platform built for execution.
Whether you are entering the market, structuring a partnership, or exploring local manufacturing, we're built for the conversation.